Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics, Inc. (SYRE) is a healthcare company (biotechnology) based in the United States. The share price is $94.82, down 4.58% on the day, which values the company at $9B. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$94.82−4.58% today
Market value
$9B
200-week average
$32.59191% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Spyre Therapeutics, Inc. in more detail

SYRE trades at -25.7× next year's expected earnings. It sits 191% above its 200-week average of $32.59.

Worth checking: Share count keeps rising.

1 of the superinvestors tracked here hold SYRE, including Brandon Haley (0.2% of the portfolio).

Superinvestors holding SYRE

1 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:SYRE vs QGEN (Spyre Therapeutics, Inc. vs Qiagen)SYRE vs PODD (Spyre Therapeutics, Inc. vs Insulet)SYRE vs MOH (Spyre Therapeutics, Inc. vs Molina Healthcare)SYRE vs BIO (Spyre Therapeutics, Inc. vs Bio-Rad Laboratories)SYRE vs PCVX (Spyre Therapeutics, Inc. vs Vaxcyte)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Spyre Therapeutics, Inc. (SYRE): questions and answers

What is Spyre Therapeutics, Inc.'s market cap?

Spyre Therapeutics, Inc. is valued at $9B at a share price of $94.82.

Is SYRE above its 200-week moving average?

Yes. SYRE is 190.9% above its 200-week average of $32.59. Long-term investors watch that line because strong companies rarely trade below it for long.

Does SYRE pay a dividend?

Spyre Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own SYRE?

In their latest quarterly filings, Brandon Haley (0.2% of the portfolio) hold SYRE. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Spyre Therapeutics, Inc. (SYRE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SYRE

Underlying data: Yahoo Finance; company filings with the SEC.